🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, open-label, single-arm investigator-initiated clinic...
Status
Not Yet Recruiting
Location
Peking University Third Hospital
Start Date
2024-10-16
Trial ID
NCT06645197
Treatments Being Tested
This study is a multicenter, randomized, controlled, open-label, phase II s...
Status
Unknown
Location
Multiple Locations
Start Date
2021-09
Trial ID
NCT04983550
Treatments Being Tested
This is an open-label, multi-center, multi-cohort, phase Ib/II clinical tri...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-13
Trial ID
NCT06682611
Treatments Being Tested
This study is an open, single-arm, multicenter phase II study to investigat...
Status
Unknown
Location
National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2021-07-31
Trial ID
NCT04886700
Treatments Being Tested
This is a single-arm, open-label, multicenter, phase II study to evaluate t...
Status
Unknown
Location
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Start Date
2021-10-01
Trial ID
NCT05068141
Treatments Being Tested
Efficacy and Safety of SYHX2011 Combined with Carboplatin and Enlonstobart ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-01
Trial ID
NCT07662811
Treatments Being Tested
This study is an open-label, phase II study of irinotecan liposome injectio...
Status
Terminated
Location
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
Start Date
2021-09-01
Trial ID
NCT05009953
Treatments Being Tested
The study is a multicenter, open-label, phase Ib/II study to evaluate the e...
Status
Not Yet Recruiting
Location
Shandong Tumor Hospital
Start Date
2023-12
Trial ID
NCT06136988
This study is a phase Ⅱ, randomized, controlled, open-label, multi-center s...
Status
Unknown
Location
Multiple Locations
Start Date
2024-01
Trial ID
NCT06089330
Treatments Being Tested
This study is an open, multi-dose, dose escalation and cohort expansion, ph...
Status
Unknown
Location
Shanghai East Hospital
Start Date
2019-05-23
Trial ID
NCT03852823
Treatments Being Tested